Table 1 Baseline characteristics of included patients
Clinical features | Value |
|---|---|
Mean age at diagnosis ± SD (years) | 55 ± 13 |
Mean height ± SD (cm) | 171.6 ± 7.55 |
Mean weight ± SD (kg) | 78 ± 16 |
Sex (n) | |
Female | 7 |
Male | 12 |
ECOG performance status (n) | |
0 | 11 |
1 | 7 |
2 | 1 |
3–4 | 0 |
Histological subtype (n) | |
Classical Hodgkin lymphoma | 6 |
DLBCL | 4 |
Follicular lymphoma | 3 |
Mantle-cell lymphoma | 3 |
T-cell lymphoma | 1 |
Poppema | 1 |
Grey zone lymphoma | 1 |
Tumour stage (n) | |
IE | 1 |
II A | 3 |
II B | 4 |
III | 2 |
IV | 9 |
Bone marrow biopsy involvement (n) | |
Negative | 13 |
Positive | 5 |
Unknown | 1 |
Nodal site (n) | 18 |
Extra-nodular site (n) | |
Spleen | 3 |
Lung | 1 |
Liver | 1 |
Skin | 1 |
Tongue | 1 |
Mean LDH level ± SD (UI/L) | 485 ± 256 |
Chemotherapy type (n) | |
ABVD | 7 |
R-CHOP | 6 |
None | 3 |
Bendamustine | 1 |
R-CVP | 1 |
ACVBP | 1 |
Prophylactic intrathecal methotrexate | |
Yes | 2 |
No | 17 |
Number of patients analysed (n) | 19 |
Total number of patients (n) | 21 |